See All Slides - tctmd.com

Slides

Presentation Intravascular Coronary Imaging and Physiology 2016

Live Case # 2: Utilization of OCT during PCI

Presenter: Richard Shlofmitz

March 10, 2016

Presentation Scripps 2016

Balancing Expectations with Evidence-based Care: Best Practice Initiatives

Presenter: Elizabeth M. Perpetua

February 02, 2016

Presentation Fellows 2016

Evaluation and Management of Carotid Arterial Disease

Presenter: Sahil A. Parikh, William A. Gray

April 17, 2016

Presentation JIM 2016

Direct Flow Medical: Latest Data on a Unique Structural Heart Technology

Presenter: Azeem Latib

February 10, 2016

Presentation

Choice of Treatment for Aortic Valve Stenosis in the Era of TAVR in Eastern Denmark (2005-2015)

Presenter: Ole De Backer

June 01, 2016

Presentation ESC 2016

NIPPON Randomized Study: 6 Months vs 18 Months Dual Antiplatelet Treatment For Patients Underwent Bioabsorbable Polymer And Abluminal Coated DES Deployment

Presenter: Masato Nakamura

August 28, 2016

Presentation JIM 2016

SAPIEN 3: Current Experience

Presenter: Martin B. Leon

February 09, 2016

Presentation TVT 2016

Study Design for the EVOLUT R Low-Risk Trial

Presenter: Jeffrey J. Popma

June 16, 2016

Presentation TVT 2016

TVT 1127: Persistent Transcathter Valve Thrombosis Despite Full Anticoagulation

Presenter: Leo Marcoff, MD

June 16, 2016

Presentation

Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With Sapien 3

Presenter: Oliver Husser

February 04, 2016

Advertisement

Slides

Live Case # 2: Utilization of OCT during PCI

Balancing Expectations with Evidence-based Care: Best Practice Initiatives

Evaluation and Management of Carotid Arterial Disease

Direct Flow Medical: Latest Data on a Unique Structural Heart Technology

Choice of Treatment for Aortic Valve Stenosis in the Era of TAVR in Eastern Denmark (2005-2015)

NIPPON Randomized Study: 6 Months vs 18 Months Dual Antiplatelet Treatment For Patients Underwent Bioabsorbable Polymer And Abluminal Coated DES Deployment

SAPIEN 3: Current Experience

Study Design for the EVOLUT R Low-Risk Trial

TVT 1127: Persistent Transcathter Valve Thrombosis Despite Full Anticoagulation

Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With Sapien 3

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content